[1] Kirkham, S., Akilen, R., Sharma, S., & Tsiami, A. (2009). The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes, Obesity and Metabolism, 11(12), 1100–1113. https://doi.org/10.1111/j.1463-1326.2009.01094.x

[2] Jarvill-Taylor, K. J., Anderson, R. A., & Graves, D. J. (2001b). A Hydroxychalcone Derived from Cinnamon Functions as a Mimetic for Insulin in 3T3-L1 Adipocytes. Journal of the American College of Nutrition, 20(4), 327–336. https://doi.org/10.1080/07315724.2001.10719053

[3]Askari, F., Rashidkhani, B., & Hekmatdoost, A. (2014). Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutrition Research, 34(2), 143–148. https://doi.org/10.1016/j.nutres.2013.11.005

[4] Baskaran, K., Ahamath, B. I., Shanmugasundaram, K. R., & Shanmugasundaram, E. (1990). Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. Journal of Ethnopharmacology, 30(3), 295–305. https://doi.org/10.1016/0378-8741(90)90108-6

[5] Klein, G., Kim, J., Himmeldirk, K., Cao, Y., & Chen, X. (2007). Antidiabetes and Anti-Obesity Activity ofLagerstroemia speciosa. Evidence-based Complementary and Alternative Medicine, 4(4), 401–407. https://doi.org/10.1093/ecam/nem013

[6] Stohs, S. J., Miller, H. L., & Kaats, G. R. (2012). A Review of the Efficacy and Safety of Banaba (Lagerstroemia speciosa L.) and Corosolic Acid. Phytotherapy Research, 26(3), 317–324. https://doi.org/10.1002/ptr.3664

[7] Miura, T., Takagi, S., & Ishida, T. (2012). Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosaL.) and Corosolic Acid. Evidence-based Complementary and Alternative Medicine, 2012, 1–8. https://doi.org/10.1155/2012/871495

[8]Klein, G., Kim, J., Himmeldirk, K., Cao, Y., & Chen, X. (2007c). Antidiabetes and Anti-Obesity Activity ofLagerstroemia speciosa. Evidence-based Complementary and Alternative Medicine, 4(4), 401–407. https://doi.org/10.1093/ecam/nem013

[9]Miura, T., Takagi, S., & Ishida, T. (2012b). Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosaL.) and Corosolic Acid. Evidence-based Complementary and Alternative Medicine, 2012, 1–8. https://doi.org/10.1155/2012/871495

[10] Klein, G., Kim, J., Himmeldirk, K., Cao, Y., & Chen, X. (2007d). Antidiabetes and Anti-Obesity Activity ofLagerstroemia speciosa. Evidence-based Complementary and Alternative Medicine, 4(4), 401–407. https://doi.org/10.1093/ecam/nem013

[11] Stohs, S. J., Kaats, G. R., & Preuss, H. G. (2016). Safety and Efficacy of Banaba– Moringa oleifera –Green Coffee Bean Extracts and Vitamin D3 in a Sustained Release Weight Management Supplement. Phytotherapy Research, 30(4), 681–688. https://doi.org/10.1002/ptr.5577

[12] Banaba (Lagerstroemia speciosa L.): an evidence-based systematic review by the Natural Standard research collaboration. (2007). PubMed. https://www.ncbi.nlm.nih.gov/pubmed/17594991

[13] Stohs, S. J., Miller, H. L., & Kaats, G. R. (2012d). A Review of the Efficacy and Safety of Banaba (Lagerstroemia speciosa L.) and Corosolic Acid. Phytotherapy Research, 26(3), 317–324. https://doi.org/10.1002/ptr.3664

[14] Miura, T., Takagi, S., & Ishida, T. (2012c). Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosaL.) and Corosolic Acid. Evidence-based Complementary and Alternative Medicine, 2012, 1–8. https://doi.org/10.1155/2012/871495

[15] Novkovic, B. (2023). Alpha-Lipoic Acid Benefits: Skin, Neuropathy, Weight & More. SelfHacked. https://www.selfhacked.com/blog/lipoic-acid/#Health_Benefits_of_Lipoic_Acid

[16] Sharman, J. E., Gunaruwan, P., Knez, W. L., Schmitt, M., Marsh, S. A., Wilson, G. S., Cockcroft, J. R., & Coombes, J. S. (2004). Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men. British Journal of Clinical Pharmacology, 58(3), 243–248. https://doi.org/10.1111/j.1365-2125.2004.02146.x

[17] As, A., Barinov, A., Dyck, P. J., Hermann, R. E., Kozlova, N. A., Litchy, W. J., Low, P. A., Nehrdich, D., Novosadova, M., O’Brien, P., Reljanovic, M., Samigullin, R., Schuette, K., Strokov, I., Tritschler, H. J., Wessel, K., Yakhno, N., & Ziegler, D. (2003). The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid. Diabetes Care, 26(3), 770–776. https://doi.org/10.2337/diacare.26.3.770

[18] Zeigler, D., As, A., Barinov, A. N., Dyck, P. J., Gurieva, I., Low, P. A., Munzel, U., Yakhno, N., Raz, I., Novosadova, M., Maus, J., & Samigullin, R. (2006). Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy. Diabetes Care, 29(11), 2365–2370. https://doi.org/10.2337/dc06-1216

[19] Tang, J., Wingerchuk, D. M., Crum, B. A., Rubin, D. I., & Demaerschalk, B. M. (2007). Alpha-Lipoic Acid May Improve Symptomatic Diabetic Polyneuropathy. The Neurologist, 13(3), 164–167. https://doi.org/10.1097/01.nrl.0000263703.78318.2b

[20] Busko, M. (2019c, April 12). Lifetime Cost of Treating Diabetes in US: Around $85,000. Medscape. https://www.medscape.com/viewarticle/809547

[21] American Medical Association. (2018b, November 14). Prediabetes campaign: 1 in 3 in U.S. has prediabetes, learn your risk. https://www.ama-assn.org/press-center/press-releases/prediabetes-campaign-1-3-us-has-prediabetes-learn-your-risk#:~:text=More%20than%201%20in%203,in%20the%20past%2020%20years.

[22] Website, N. (n.d.-c). Side effects of metformin. nhs.uk. https://www.nhs.uk/medicines/metformin/side-effects-of-metformin/

[23] Robinson, A. (2023c, February 1). 15 Statistics Everyone Should Know about Diabetic Foot & Leg Amputations. USA Vascular Centers. https://www.usavascularcenters.com/blog/pad-and-diabetic-amputation-statistics/#:~:text=Every%20year%20in%20the,performed%20on%20people%20with%20diabetes

[24] Lee, R., Wong, T. Y., & Sabanayagam, C. (2015c, September 30). Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye And Vision. https://doi.org/10.1186/s40662-015-0026-2

[25] ResearchFDA Updates and Press Announcements on NDMA in Metformin. U.S. Food And Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-metformin

[26] Mainous, A. G., Diaz, V. A., Saxena, S., Baker, R., Everett, C. J., Koopman, R. J., & Majeed, A. (2006d, September 1). Diabetes management in the USA and England: comparative analysis of national surveys. Journal of the Royal Society of Medicine.

[27] Dillinger, K. (2022c, December 29). Diabetes rates may surge in US young people, study finds. CNN. https://www.cnn.com/2022/12/29/health/diabetes-young-people/index.html#:~:text=The%20number%20of%20people%20under,people%20with%20type%201%20diabetes.

[28] Miura, T., Takagi, S., & Ishida, T. (2012c). Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosaL.) and Corosolic Acid. Evidence-Based Complementary and Alternative Medicine, 2012, 1–8. https://doi.org/10.1155/2012/871495

[29] Nianogo, R. A., & Arah, O. A. (2022, April 5). Forecasting Obesity and Type 2 Diabetes Incidence and Burden: The ViLA-Obesity Simulation Model. https://www.frontiersin.org/articles/10.3389/fpubh.2022.818816/full#:~:text=Obesity%20(and%20overweight)%20is%20considered,patients%20are%20overweight%20or%20obese